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Abstract: Single-walled carbon nanotubes (SWCNTs) are characterized by a combination of rather
unique physical and chemical properties, which makes them interesting biocompatible nanostructured materials for various applications, including in the biomedical field. SWCNTs are not inert
carriers of drug molecules, as they may interact with various biological macromolecules, including
ion channels. To investigate the mechanisms of the inhibitory effects of SWCNTs on the muscarinic
receptor cation current (mICAT) , induced by intracellular GTPγs (200 µM), in isolated mouse ileal
myocytes, we have used the patch-clamp method in the whole-cell configuration. Here, we use
molecular docking/molecular dynamics simulations and direct patch-clamp recordings of whole-cell
currents to show that SWCNTs, purified and functionalized by carboxylation in water suspension
containing single SWCNTs with a diameter of 0.5–1.5 nm, can inhibit mICAT , which is mainly carried
by TRPC4 cation channels in ileal smooth muscle cells, and is the main regulator of cholinergic
excitation–contraction coupling in the small intestinal tract. This inhibition was voltage-independent
and associated with a shortening of the mean open time of the channel. These results suggest
that SWCNTs cause a direct blockage of the TRPC4 channel and may represent a novel class of
TRPC4 modulators.
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Single-walled carbon nanotubes (SWCNTs) have become a hot research area because
of their unique physico-chemical properties and prospects for various applications in nanotechnology. Owing to their nanosize, good biocompatibility, stability and high reactivity,
SWCNTs can be widely used in biomedicine [1–3]. It has been reported that SWCNTs
penetrate the cells via endocytosis-dependent and independent pathways [4–6]. They can
affect neuronal activity [7], most likely at the level of ion channels [8]. SWCNTs have been
defined as neuroprotectors [9] and effective substrates for the culturing of neurons [10].
As a nanoplatform, SWCNTs can be used for imaging and drug delivery [11,12]. We were
the first to show that SWCNTs modulate cardiovascular control in rats [13]. However, the
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biomedical applications of SWCNTs are limited by their possible toxicity, so their biosafety
is currently one of the most discussed issues. At present, information on SWCNT toxicity
remains controversial [14–16]. The toxic effect of SWCNTs on normal cells and living
systems is determined by the following factors: chemical composition, size, dose and
exposure route [17,18]. Previously, we have reported that the systemic introduction of
0.1 mg/mL carboxylated SWCNTs (diameter of 0.5–1.5 nm) does not have any adverse
effects is rats [19].
Earlier electrophysiological studies have shown that pristine SWCNTs (with diameter
distributions peaking at approximately 0.9 and 1.3 nm) [20], as well as functionalized
SWCNTs [8], can interact with various proteins, such as ion channels and receptors. In
particular, they effectively block, in a dose-dependent manner, several different types of K+
channels heterologously expressed in mammalian cells. An electrical system based on a
network of semiconducting nanotubes was developed to detect single ion channel activity
by measuring the dynamic opening and closing of the individual ion channels using
SWCNTs [8]. Moreover, SWCNTs were found to mimic some aspects of ion permeation
via channel-forming proteins [21]. Such ion transport via SWCNTs (diameter of 1.2–2 nm)
may even mimic some of the fundamental properties of ion channels, such as their voltage
dependence [22].
We have previously characterized C60 fullerenes as novel inhibitors of large-conductance
Ca2+ -activated K+ channels in pulmonary artery myocytes [23] and the muscarinic receptor
cation current, termed mICAT , in ileal smooth muscle cells [24]. The latter current is
mediated by both TRPC4 and TRPC6 proteins, with TRPC4 acting as its main molecular
component [25]. Activated under physiological conditions by acetylcholine, mICAT is
well recognized as the principal regulator of cholinergic excitation–contraction coupling
in gastrointestinal smooth muscles [26,27]. Several inhibitors of this current are known,
including ML204 [28], polyamines [29] and SK&F 96,365 [30]. In this study, we aimed to
investigate the effects of SWCNTs on mICAT using both molecular modeling and direct
patch-clamp recordings of whole-cell currents.
2. Materials and Methods
2.1. Preparation and Characterization of SWCNTs Water Suspension
SWCNTs were synthesized by means of the arc-discharge technique between two
graphite electrodes in a He atmosphere (700 mbar) [5,31]. The anode was drilled and filled
with catalytic powder (graphite, 1% Y2 O3 , 4.2% NiO). The arc-discharge was performed
with a current of 150 A. The contaminants, such as amorphous carbon and metallic catalyst
particles, were removed after treatment with boiling HCl (6 M) in a reflux condenser.
For the characterization of the SWCNTs, we applied high-resolution transmission
electron microscopy (HRTEM, Tecnai 20 S-Twin, Beijing, China). According to the HRTEM
micrographs, the diameter and the length of SWCNTs are 0.5–2 nm and 1–5 µm, respectively.
Additionally, we also employed thermogravimetric analysis (TGA, Sartorius MC5, Wood
Dale, IL, USA) in air before acid treatment. The TGA produced an unburned residue
(catalyst particles) at T = 1323 K of 5 m% due to residual catalyst particles.
The functionalization (carboxylation) of SWCNTs was accomplished by HNO3 (3 M)
treatment for 2 h at T = 373 K with the aim of improving their hydrophilicity. The chemical
composition of the samples was characterized by X-ray photoelectron spectroscopy (XPS)
measurements in normal emission using an ultra-high-vacuum (UHV) system equipped
with a Physical Electronics 10-610 X-ray source [32]. The functionalized SWCNTs were
suspended in distilled water by ultrasonication (UZDN-1 U42, Russia); 21 kHz; 0.68 A,
processing time of 90 s at constant heat removal) allowing dissolution of some SWCNTs in
water. The obtained suspension was filtered out by means of a membrane filter (pore size
was 1.2 µm). The maximum concentration of SWCNTs in water (0.1 mg/mL) was determined (Analytik Jena TOC Analyser multi N/C 3100, Jena, Germany) as the concentration
of total organic carbon in the water suspension.
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The purity of prepared SWCNT water suspension was determined by high-performance
liquid chromatography (Jasco PU-2086, Tokyo, Japan) and GC/MS using standard programs. Insoluble impurities were determined by ultracentrifugation. The insoluble impurities in the prepared SWCNT water suspension were found to be less than 1 µg/mL. The
SWCNT water suspension was stable for about three months at T = 283 K [33].
In order to characterize the composition of the prepared SWCNTs water suspension,
atomic force microscopy (AFM) was performed. According to the AFM results, the majority
of SWCNTs in water suspension (0.1 mg/mL) appear as aggregates (bundles) with a height
of up to 40 nm [5]. However, non-aggregated, i.e., single, SWCNTs with a diameter of
0.5–1.5 nm, which can interact with the TRPC4 channel pore and are consistent with the
selected computed molecular models (see below), were also present [19].
2.2. Molecular Docking
Prior to molecular docking, it was taken into consideration that the diameter of tested
SWCNTs was in the range of 0.4–20 nm. Therefore, all possible SWCNTs were generated
using a CHARMM-GUI nanomaterial modeler [34–37]. Based on the structural analysis
and TRPC4 location in the lipid membrane according to PDBTM [38] and PMM [39], we
simulated SWCNT interaction with the TRPC4 channel pore.
Molecular docking was performed by utilizing the flexible SWCNT and rigid TRPC4
channel. A systematic docking algorithm was used (SDOCK+) [40], implemented in the
QXP package [41] (the method demonstrates all possible conformations of the studied
structures with a minimum RMSD value [40]). In total, 300 possible “SWCNT-TRPC4”
complexes were generated for all considered SWCNTs. Then, the 10 best complexes were
selected using QXP scoring functions [41] for the next stages (visual inspection). The
optimal structure of the studied “SWCNT-TRPC4” complexes was determined by the
following basic criteria: (1) the number of hydrogen bonds; (2) the area of the contact
surfaces of the protein and ligand; (3) the distance between the protein and ligand; (4) the
energy characteristics of the binding in the formed complex.
2.3. Molecular Dynamics (MD) Simulation
CHARMM-GUI Membrane Builder [42–47] was used for POPC (palmitoyl oleoyl
phosphatidylcholine) membrane creation by adding of missed amino acids to the TRPC4
channel (Q9QUQ5 sequence was used) and embedding the TRPC4 channel into 700 POPC
molecules, according to the PMM server [39] (Figure 1). The POPC membrane and TRPC4
channel modeled in the CHARMM-GUI Membrane Builder were energy-minimized and
equilibrated in an environment similar to cellular content (water box with 0.15 M Na+ and
Cl− ions concentration). The protein was protonated according to the built-in functions of
gromacs 2020. All calculations were performed using gromacs 2020 (http://www.gromacs.
org/, last accessed date 11 June 2021) in a force field Charmm36 [48] at 300 K and at
constant atmospheric pressure. Finally, the MD simulation lasted 50 ns.
2.4. Cell Isolation
All electrophysiological studies were performed using freshly isolated smooth muscle
cells of murine small intestine. For the study, 3-month-old BALB/c male mice were
used. All animal studies using BALB/c mice were carried out in accordance with the
recommendations of the EU Directive 2010/63 on the protection of animals used for
scientific purposes and approved by the Institutional Ethics Committee (No. 04/20).
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Figure 1. (A) Molecular model of receptor-operated TRPC4 cation channel (PDB ID 5Z96) with its
four subunits shown by different colors: subunit A—red, subunit B—blue, subunit C—green, and
subunit D—yellow. (B) Profile view of TRPC4 channel. (C) Top view of TRPC4 channel. In both
(B) and (C), the plasma membrane is highlighted in green, and an example of single-walled carbon
nanotube (SWCNT) docked into the TRPC4 channel pore is shown in grey.

Mice were humanely euthanized by CO2 asphyxia, then the abdominal cavity was
opened and the longitudinal smooth muscle layer of the ileum was isolated and placed
into modified normal Krebs solution of the following composition (in mM): 120 NaCl,
12 glucose, 10 HEPES, 6 KCl, 2.5 CaCl2 , 1.2 MgCl2 , pH adjusted to 7.4 with NaOH. The
tissue was cut into small 1 mm pieces in Ca, Mg-free Krebs solution (in mM: 120 NaCl,
12 glucose, 10 HEPES, 6 KCl, pH adjusted to 7.4 with NaOH) and enzymatically treated in
a mixture of collagenase type 1A, soybean trypsin inhibitor and bovine serum albumin (all
reagents were used at 1 mg/mL) at 37 ◦ C for 17 min. Then, tissue pieces were washed out
three times from enzymes and mechanically triturated with a heat-polished glass Pasteur
pipette until a cloudy appearance was obtained in the solution. The cell suspension was
stored at 5–7 ◦ C for 6–8 h after cell isolation.
2.5. Patch Clamp Recordings
Membrane currents were recorded via the patch-clamp techniques in a whole-cell
configuration using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA, USA)
at room temperature (22–25 ◦ C). The protocols of voltage pulses were generated and data
were recorded using a Digidata 1322A interfaced to a computer running the pClamp
8 software (Molecular Devices, Sunnyvale, CA, USA).
Patch-pipettes were fabricated from borosilicate glass (1.5 mm OD, 0.86 mm ID; Sutter
Instrument, Novato, CA, USA) using a P-97 Flaming/Brown micropipette puller (Sutter
Instrument, Novato, CA, USA) with a resistance of 3–3.5 MOhm when filled with the
intracellular solution.
Before the current recordings, the cells were kept in normal Krebs solution, while for
mICAT recordings, the bath solution was replaced with a Cs+ -containing solution (in mM:
120 CsCl, 12 glucose, 10 HEPES, pH adjusted to 7.4 with CsOH). The pipette solution (in
mM: 80 CsCl, 1 MgATP, 5 creatine, 5 glucose, 10 BAPTA, 10 HEPES, 4.6 CaCl2 , pH adjusted
to 7.4 with CsOH) contained 200 µM GTPγS, which activates G-proteins directly and thus
initiates mICAT , bypassing the muscarinic receptors.
Whole-cell recordings were filtered at 2 kHz and sampled at 10 kHz for analysis. Series
resistance was compensated for by ~40%. The steady-state current–voltage relationships of
mICAT were measured by slow 6 s voltage ramps from 80 to −120 mV, which were applied
every 30 s. The holding potential was −40 mV.
2.6. Chemicals
All reagents and chemicals for electrophysiological studies were purchased from
Sigma Chemical (St. Louis, MO, USA).
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2.7. Data and Statistical Analysis
Patch-clamp data were analyzed and plotted using Clampfit 8 (Molecular Devices,
Sunnyvale, CA, USA) and OriginPro 2021 software (OriginLab Corporation, Northampton,
MA, USA). Data are presented as means ± SEM (standard error of the mean) with n
indicating the number of cells used for a particular set of measurements. The Kolmogorov–
Smirnov normality test was used, while differences between two groups were evaluated
using Student’s paired t-test and considered significant at p < 0.05.
3. Results
3.1. Modeling of SWCNT Binding to TRPC4 Channel
To evaluate the possibility of SWCNT binding to the TRPC4 channel, we applied
computer simulation techniques, namely, molecular docking and molecular dynamics
(MD). Molecular docking is among the most frequently used numerical techniques, due to
its ability to predict the binding-conformation of small molecule ligands to the appropriate
target binding site [49]. MD simulation is also one of the most frequently used techniques
to evaluate the stability of the “ligand-protein (target)” molecular system [23,50].
The molecular model of the homotetrameric receptor-operated TRPC4 cation channel
(mouse TRPC4 ion channel, PDB ID 5Z96) is shown in Figure 1. As a result of molecular
docking, three optimal “SWCNT-TRPC4” complexes were selected (Figure 2, left). The
first one is based on an SWCNT with a diameter of ~0.7 nm (SWCNT_1 model) (Figure 2A,
left). In this case, SWCNT perpendicularly interacts within the plane of the TRPC4 channel
pore and the palmitoyl oleoyl phosphatidylcholine (POPC) bilayer, and also undertakes
similar interactions with each subunit of the TRPC4 channel (see Figure 1). Specifically,
these interactions include the following: steric interaction with Asn 580 and Glu 555, cationπ-with Lys 556, and the possibility of t-stacking with Tyr 582. In the second model, an
SWCNT (SWCNT_2 model) with a diameter of ~1.5 nm was used (Figure 2B, left). As in the
first model, this SWCNT also binds perpendicularly to the plane of the TRPC4 channel and
the POPC bilayer. However, an SWCNT cannot sink into the channel pore, and interacts
only with its top part. As a result, the interaction between TRPC4 and SWCNT is weak:
it is just a steric interaction with Leu 547, Lys 556 and Glu 555. Finally, in the last model,
an SWCNT with a diameter of 1.5 nm was used (SWCNT_3 model shown in Figure 2C,
left). In this case, an SWCNT does not interact similarly with each subunit of the TRPC4
channel. This SWCNT lies on its side, and one part partially sinks into the TRPC4 channel
pore. Such a binding mode results in binding to the B subunit of the TRPC4 channel (see
Figure 1), mostly via cation-π, of Lys 556 and Lys 587, and sterically with Glu 555, Tyr 582
and Leu 547 interactions.
To obtain more precise results, MD simulation was performed for the “SWCNTTRPC4” complexes selected based on the molecular docking findings. The results are
shown in Figure 2 (right). In all cases, SWCNTs can stably bind to the TRPC4 channel pore.
Moreover, SWCNTs do not contact each subunit of the TRPC4 channel in the same manner
as in the case of molecular docking. According to the MD simulation, the absorption of
SWCNTs by the TRPC4 extracellular loops located near the pore was observed (especially
in the SWCNT_1 and SWCNT_2 models). Furthermore, it was found that the SWCNTs,
during interaction with the TRPC4 channel, could rotate and partially interact with different
outer membrane residues of the pore in a non-symmetrical manner. Thus, in the case of
the SWCNT_1 model, SWCNT was characterized by large displacement with a root–mean–
square deviation (RMSD; value of 1.34 nm), and had strong interactions with Lys 556, Lys
587, Lys 550, Glu 555, Tyr 582 and Asn 580 (Figure 2A, right). In the case of the SWCNT_2
model, a similar situation was observed: SWCNT displacement was 0.97 nm; the main
binding residues were almost the same, except for Lys 545, Lys 587, Leu 547 and Asn 580
(Figure 2B, right). Finally, in the case of the SWCNT_3 model, the RMSD value was about
0.5 nm, and in this case, SWCNT interacted with Glu 555, Lys 587, Lys 545, Lys 587, Lys
556, Glu 555 and Leu 547 (Figure 2C, right).
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Figure 2. Results of molecular docking (left) and MD simulation (right) for SWCNTs: (A) SWCNT_1
model; (B) SWCNT_2 model, and (C) SWCNT_3 model. The TRPC4 channel is shown in yellow and
SWCNT in grey.

According to the RMSD movement of the obtained complexes, the SWCNT_1 and
SWCNT_2 models are more flexible than the unbound TRPC4 channel and the SWCNT_3
model (Figure 3).

Figure 3. The root–mean–square deviation (RMSD) trajectories of TRPC4 channel alone (in red)
and in complex with SWCNTs: SWCNT_1 model is shown in black, SWCNT_2 model in green and
SWCNT_3 model in blue.
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The RMSF (root–mean–square fluctuation) profile analysis (Figure 4) revealed that
binding with SWCNT affects the whole TRPC4 channel structure. The fluctuation of the
TRPC4 channel pore in the binding region and nearby parts was affected differently by
each SWCNT in each binding model. For example, pore flexibility (residues 545–560 and
578–587) allows for binding in the SWCNT_1 model that is almost the same as that with the
unbound TRPC4 channel in the SWCNT_2 model, but this binding is somewhat stronger
compared to the SWCNT_3 model (Figure 4). The results in other parts of the TRPC4
channel, especially the intracellular section, were surprising. For example, the movements
of residues 163–186 were different in all simulation cases (Figure 4).

Figure 4. The root–mean–square fluctuation (RMSF) profile of the TRPC4 channel alone (in red;
(A–D) subunits) and in complex with SWCNTs: the SWCNT_1 model is shown in black, SWCNT_2
model in green and SWCNT_3 model in blue.

The LJ-SR (Lennard–Jones short range) energy computed in this simulation is better
in the case of the SWCNT_2 binding model (Figure 5). Clearly, the interacting surfaces
between the TRPC4 channel and SWCNT_2 model are larger compared to the SWCNT_1
model. The LJ-SR energy of the SWCNT_3 model is about −100 kJ/mol, and it does not
change over time. In the case of the SWCNT_1 and SWCNT_2 models, the calculated LJ-SR
energy is about −300 and −400 kJ/mol in the first (0–25,000 ps) and second phases of
calculation (2500–50,000 ps), respectively.

Nanomaterials 2021, 11, 3410

8 of 15

Figure 5. The Lennard–Jones short range (LJ-SR) binding energy between the TRPC4 channel and
SWCNTs: SWCNT_1 model is shown in black, SWCNT_2 model in green and SWCNT_3 model
in blue.

In summary, we can conclude that all considered SWCNTs can interact with the TRPC4
channel by forming one or another stable bond.
3.2. Inhibitory Action of SWCNT on mICAT in Ileal Myocytes
In ileal myocytes, the TRPC4 receptor-operated cation channels are activated in synergy with M2 and M3 receptors, which are differentially coupled to Gq/11 and Gi/o proteins [51,52]. Although adding GTP to the pipette solution counteracts the desensitization of
the response to some extent [53], the current is most stable when activated by the hydrolysisresistant GTP analog GTPγS, which interacts with G-proteins directly. Figure 6A illustrates
the voltage protocol used in our experiments. For a complete assessment of both the
kinetics and voltage dependence of mICAT , a combination of voltage steps and a slow (6 s
duration) voltage ramp was applied, with the holding potential of −40 mV with an interval
of 30 s starting shortly (20–30 s, time needed to adjust membrane capacitance and series
resistance compensations) after break-through with a patch pipette containing GTPγS
(200 µM). mICAT was effectively isolated using symmetrical Cs+ -containing (125 mM) solutions, with a strong buffering intracellular free Ca2+ concentration of 100 nM employed
to avoid the complexity of its calcium-dependent regulation, such as current fluctuations
concomitant with intracellular Ca2+ oscillations [54,55]. Under these conditions, the current
slowly increased in size to reach a peak amplitude in about 5–7 min, along with gradual
accumulations in the cells of G-proteins that were spontaneously and irreversibly activated
by GTPγS (Figure 6A,C). Figure 6D illustrates the corresponding superimposed steadystate current–voltage (I-V) relationships of mICAT obtained by slow voltage ramps. The
steady-state I-V relationship was doubly rectifying around the reversal potential (EREV
close to 0 mV) and U-shaped at negative potentials, which is typical for mICAT . It can
be seen that very little run-down of the current occurred during the time course of the
experiment under control conditions (Figure 6D, traces marked as 2 and 3).
The application of SWCNTs (10 µg/mL) after the GTPγS-induced mICAT reached its
peak amplitude markedly inhibited the current (Figure 7). The inhibition developed monoexponentially with time constants of 156 and 162 s at −40 and 80 mV, respectively, as shown
by the superimposed white lines in Figure 7C. The mean time constant of mICAT inhibition
by SWCNTs at 80 mV was 180 ± 31 s (min = 109.2 s; median = 162.6 s; max = 267.6 s; n = 5).
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Figure 6. Characterization of GTPγS-induced mICAT in mouse ileal myocytes. (A) Voltage protocol
and (B) corresponding representative superimposed linear leak-corrected current traces of the cationic
current activated by GTPγS infusion. (C) Time course of GTPγS-induced mICAT development at
the three different test potentials (−40, −120 and 80 mV) as indicated by different symbols. These
represent mean current amplitudes at the holding potential of −40 mV and during the last 200 ms
of voltage steps to −120 and 80 mV. (D) Corresponding superimposed current-voltage relations of
mICAT measured by the slow (6 s duration) voltage ramp from 80 to −120 mV (A). Shown in black
are three I-V curves measured immediately after membrane break-through (A), at the peak response
to GTPγS (B) and at the end of the experiment (C), as indicated by the same letters in panel (C).

Figure 7. SWCNTs inhibit the muscarinic cation current via TRPC4 channels. (A) Voltage protocol
and (B) corresponding representative superimposed current traces of the cationic current activated by
GTPγS infusion and then suppressed by SWCNTs. (C) Time course of mICAT development in response
to GTPγS followed by its time-dependent inhibition as assessed at three different test potentials
(−40, −120 and 80 mV). Superimposed white lines show that, after SWCNT application, mICAT
mono-exponentially declined with similar time constants both at negative and positive potentials.
(D) Corresponding superimposed current–voltage relations of mICAT measured by the slow (6 s
duration) voltage ramp from 80 to −120 mV (A). Shown in black are three I-V curves measured
immediately after membrane break-through (A), at the peak response to GTPγS (B) and at the
steady-state current inhibition by SWCNTs (C), as indicated by the same letters in panel (C).
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Figure 8 shows the mean normalized I-V curves of GTPγS-induced mICAT under
control conditions and after current inhibition by SWCNTs (10 µg/mL). For quantification
of the inhibitory effect, the maximal inward current in each cell under control conditions
was normalized as 1.0, so that each cell could serve as its own control for the inhibitory
effect of SWCNTs. Its mean value was −650.4 ± 146.1 pA, decreasing to −269.2 ± 84.0 pA
after SWCNTs application (paired t-test, two-tail p value of 0.03; n = 5). Notably, mICAT
was inhibited to a similar extent in the whole range of membrane potentials, as the ratio
of currents in Figure 8 (bottom panel) shows. It should be noted that somewhat higher
values of the ratio at potentials below −90 mV are related to the smaller mICAT due to
the voltage-dependent deactivation of TRPC4 channels together with the relatively larger
nonspecific currents at these potentials.

Figure 8. SWCNTs inhibit the muscarinic cation current via TRPC4 channels in a voltage-independent
manner. Top, mean normalized I-V curves of GTPγS-induced currents at maximal current activation
in the control compared to those during mICAT steady-state inhibition by SWCNTs applied at
10 µg/mL. The grey bands represent the SEM values (n = 5). Bottom, ratio of current amplitude in
the presence of SWCNTs to that in control plotted vs. test potential.

Considering that the rate of current deactivation with the voltage step from −40 mV
to −120 mV (Figure 7A,B) reflects the mean channel open time at −40 mV55 , additional
analysis was performed by fitting current decline at −120 mV via the single exponential
function. The mean deactivation time constant was 35.2 ± 3.3 ms at peak current activation,
as assessed by GTPγS application under control conditions, reducing to 18.1 ± 3.1 ms 6 min
after SWCNTs application (paired t-test, two-tail p value of 0.018; n = 5). These findings
suggest that SWCNTs inhibit the TRPC4 channel by shortening its open state, consistently
with the results of molecular docking and MD simulations (Figures 1–5).
4. Discussion
Members of the superfamily of Ca2+ -permeable TRP channels are expressed in almost
all cells of the body, where they perform different important functions, ranging from
regulation of membrane potential and calcium signaling to signal transduction determining
cell growth, proliferation and death. In mammals, this superfamily of cation channels
consists of 28 members subdivided into 6 subfamilies based on their structural similarities,
namely, TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin), TRPP
(polycystin), and TRPML (mucolipin) [56]. Notwithstanding substantial differences in their
intracellular carboxy- and amino-terminus, all TRPs have similar membrane topologies,
including six transmembrane domains (S1–S6), with the pores of the channel formed by S5
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and S6 domains, as well as P-loop. Within this superfamily, seven members of the canonical
TRPC subfamily (TRPC1-TRPC7) are all calcium-permeable receptor-operated channels,
which are commonly activated downstream of phospholipase C activation, and carry out
diverse regulatory functions in the nervous system, heart, lung, vasculature, immune cells
and gastrointestinal tract [56].
In the present study, we focused on TRPC4 channels, specifically on their role as the
principal molecular component of mICAT [25]. Other functions of TRPC4, as revealed by
the knockdown of TRPC4 expression in native cells and studies of TRPC4 knockout mice,
include the regulation of endothelial permeability, vascular tone, and neurotransmitter
release. Moreover, TRPC4 channels have been implicated in epileptogenesis, excitotoxicity
and urinary bladder overreactivity. Thus, TRPC4 channels are believed to be promising
molecular targets for pharmacological interventions in treating several disease states [57].
However, presently, there are only two known potent and specific blockers of TRPC4
channels, ML204 [28], and the more recently developed synthetic compound Pico145 [58].
Although we have previously documented the inhibitory action of C60 fullerenes on
mICAT in ileal myocytes [24], our biophysical analysis has shown that C60 fullerenes are
unlikely to be direct channel blockers of TRPC4; rather, they are likely to accumulate in the
membrane and disrupt G-protein mediated signaling, leading to channel opening, thus
acting as channel gating modifiers. In contrast, the inhibition of mICAT by SWCNTs was
shown to be voltage-independent (Figure 8), thus evidencing that molecular interactions
with channel proteins occurred outside of the membrane voltage field, e.g., within the
extracellular part of the channel. This notion is generally consistent with our in silico
molecular modeling predictions. Depending on the size of SWCNT nanoparticles, three
optimal binding models were considered, all of which demonstrated stable binding. In
the case of SWCNTs of 0.7–1.5 nm size, interactions occurred within the plane of the
TRPC4 channel pore and the POPC bilayer (our SWCNT_1 and SWCNT_2 models). The
SWCNT_3 model predicted that a SWCNT could even partially sink into the TRPC4
channel pore. Thus, molecular modeling predicts channel pore hindrance for cation
entry into the channel, the result of which is generally consistent with our experimental
findings showing voltage-independent inhibition and some shortening of the mean open
time of the channel. Future mutagenesis experiments can address the specific roles of
certain amino acid residues in SWCNTs binding to definitively show the SWCNTs–TRPC4
interaction. However, such experiments have certain limitations/drawbacks. First, channel
mutagenesis will necessitate the heterologous expression of the mutant channels, while the
main purpose and advantage of our study was to characterize SWCNTs’ action on native
mICAT . Second, interacting surfaces between SWCNTs and the TRPC4 protein can be quite
large, as up to seven amino acid residues in each of the four pore-forming subunits are
involved, according to our molecular docking and MD simulations (Figure 2). Third, the
mutagenesis of amino acid residues at a channel’s pore is likely to have multiple effects
on ion permeation and channel gating; some may even render the channel inactive, thus
requiring additional controls.
SWCNTs, with a diameter of about 1.3 nm, have been previously shown to inhibit,
in the same concentration range, several types of K+ channels expressed in CHO cells,
including HERG, but not chloride CLC3 channels [20]. Taken together with our present
results, a more general picture now emerges that these nanostructured materials may
represent a new class of general cation channel blockers. In contrast, we found that
C60 fullerenes inhibited TRPC4 and large-conductance Ca2+ -activated K+ channels, but
not voltage-gated K+ channels [23,24]. Thus, as ion channel blockers, compared to C60
fullerenes, SWCNTs are less discriminative, and considering their HERG effects [20], they
may even be cardiotoxic.
While it remains to be seen whether or not SWCNTs may be useful for the correction of intestinal motility disorders associated with visceral cholinergic smooth muscle
hyperactivity, such as irritable bowel syndrome, our study is of particular interest in connection with one of the proposed biomedical applications of carbon nanotubes, namely,
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as carriers for the delivery of drugs, especially anti-cancer drugs. Since Cheung et al. [59]
have demonstrated the involvement of TRPC4 and TRPC5 channels in adverse reactions to
the potent cancer cell-specific cytotoxic agent (-)-Englerin A, situations may be envisaged
wherein TRPC4 channel inhibition by SWCNTs carrying anti-cancer drugs may even be
beneficial. However, the full assessment of such potential benefits requires additional
studies, including evaluations of the concentration dependence and reversibility of the
inhibitory action of SWCNTs on mICAT .
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